Recent social and legal responses to novel psychoactive drugs (NPDs) have been attributed to media panics rather than these substance’s actual harms. NPDs, including botanical substances new to Western markets such as Salvia divinorum, newly synthesized analogues such as synthetic cannabinoids and “bath salts,” and new ways of administering drugs, such as combining prescription cough syrup with soda (“purple drank”) have been the target of various forms of legislation at the state and/or federal level. We systematically examine print media coverage of NPDs in the U. S. between 2005 and 2013 to determine whether media attention was temporally associated with legislative change. Results indicate that each drug had a brief window during which ...
Background: A plant with dissociative and psychoactive properties began to attract the attention of ...
Several hundred new synthetic drugs, novel psychoactive substances (NPS) or “legal highs” have in re...
As new psychoactive substances (NPS) flood the market and “designer drug” sales are on the rise, we ...
There has been growing clinical, public, and media awareness and concern about the availability and ...
In the last decade, the trend of drug consumption has completely changed, and several new psychoacti...
There has been growing clinical, public, and media awareness and concern about the availability and ...
Objectives There are multifaceted views on the use of ketamine, a potentially addictive substance, t...
Background Having first appeared in Europe, synthetic cannabis emerged as a drug of concern in Austr...
In recent years, use of substances commonly referred to as ‘legal highs’ has become a significant co...
OBJECTIVES:There are multifaceted views on the use of ketamine, a potentially addictive substance, t...
The story of criminal sanctions in modern America is a familiar-and depressing narrative. According ...
This Brief explores emerging trends in drug use and distribution. This timely Brief examines rec...
This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions f...
Novel psychoactive drugs (NPDs) such as synthetic marijuana, bath salts, and salvia have increasingl...
Novel psychoactive drugs (NPDs) such as synthetic marijuana, bath salts, and salvia have increasingl...
Background: A plant with dissociative and psychoactive properties began to attract the attention of ...
Several hundred new synthetic drugs, novel psychoactive substances (NPS) or “legal highs” have in re...
As new psychoactive substances (NPS) flood the market and “designer drug” sales are on the rise, we ...
There has been growing clinical, public, and media awareness and concern about the availability and ...
In the last decade, the trend of drug consumption has completely changed, and several new psychoacti...
There has been growing clinical, public, and media awareness and concern about the availability and ...
Objectives There are multifaceted views on the use of ketamine, a potentially addictive substance, t...
Background Having first appeared in Europe, synthetic cannabis emerged as a drug of concern in Austr...
In recent years, use of substances commonly referred to as ‘legal highs’ has become a significant co...
OBJECTIVES:There are multifaceted views on the use of ketamine, a potentially addictive substance, t...
The story of criminal sanctions in modern America is a familiar-and depressing narrative. According ...
This Brief explores emerging trends in drug use and distribution. This timely Brief examines rec...
This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions f...
Novel psychoactive drugs (NPDs) such as synthetic marijuana, bath salts, and salvia have increasingl...
Novel psychoactive drugs (NPDs) such as synthetic marijuana, bath salts, and salvia have increasingl...
Background: A plant with dissociative and psychoactive properties began to attract the attention of ...
Several hundred new synthetic drugs, novel psychoactive substances (NPS) or “legal highs” have in re...
As new psychoactive substances (NPS) flood the market and “designer drug” sales are on the rise, we ...